Core/Shell nanoparticles with lecithin lipid cores for protein delivery.
Core/shell nanoparticles with lipid core, were prepared and characterized as a sustained delivery system for protein. The lipid core is composed of protein-loaded lecithin and the polymeric shell is composed of Pluronics (poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) triblock copolymer, F-127). Based on the preparation method in the previous report by us, the freeze-drying of protein-loaded lecithin was performed in the F-127 aqueous solution containing trehalose used as a cryoprotectant to form stabilized core/shell nanoparticles. Cryo-TEM (transmittance electron microscopy) and a particle size analyzer were used to observe the formation of stabilized core/shell nanoparticles. For the application of core/shell nanoparticles as a protein drug carrier, lysozyme and vascular endothelial growth factor (VEGF) were loaded into the core/shell nanoparticles by electrostatic interaction, and the drug release pattern was observed by manipulating the polymeric shell.
Oh
Keun Sang
KS
Department of Polymer Science and Engineering, Hannam University, 133 Ojeong Dong, Daedeog Ku, Taejeon, Korea.
Han
Sung Kyun
SK
Lee
Hyun Suk
HS
Koo
Hyoung Mo
HM
Kim
Ree Sun
RS
Lee
Kyung Eun
KE
Han
Sung Sik
SS
Cho
Sun Hang
SH
Yuk
Soon Hong
SH
D000818:Animals; D004337:Drug Carriers / Q000737:chemistry*; D006801:Humans; D009113:Muramidase / Q000737:chemistry*; D049329:Nanostructures / Q000737:chemistry* / Q000648:ultrastructure; D010713:Phosphatidylcholines / Q000737:chemistry*; D020442:Poloxamer / Q000737:chemistry*; D042461:Vascular Endothelial Growth Factor A / Q000737:chemistry*
D004337:Drug Carriers; D010713:Phosphatidylcholines; D042461:Vascular Endothelial Growth Factor A; D020442:Poloxamer; D009113:Muramidase